|Bid||596.86 x 800|
|Ask||597.54 x 1000|
|Day's range||595.04 - 600.65|
|52-week range||497.83 - 672.34|
|Beta (5Y monthly)||0.83|
|PE ratio (TTM)||31.78|
|Earnings date||25 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||1.20 (0.20%)|
|Ex-dividend date||14 Sept 2022|
|1y target est||662.93|
Investors are optimistic about Thermo Fisher's (TMO) better-than-expected results and robust international performance.
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.